Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRACULUM: Prolgolimab in Advanced Melanoma
NCT03269565Phase 2Unknown
- Sponsor
- BIOCAD
- Start
- Aug 2017
- Primary completion
- Aug 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of prolgolimab in melanoma, sponsored by BIOCAD. Status: unknown.
02
Drugs
prolgolimab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT03269565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03269565.